期刊中文名:澳大利亞處方醫(yī)師ISSN:0312-8008E-ISSN:1839-3942
該雜志國際簡稱:AUST PRESCR,是由出版商N(yùn)ational Prescribing Service出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。
《Australian Prescriber》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱澳大利亞處方醫(yī)師,本刊主要出版、報(bào)道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.4,最新CiteScore 指數(shù)為3.8。
Australian Prescriber is a journal for healthcare professionals whose primary purpose is to provide independent, reliable and easily accessible information to help doctors, pharmacists and other healthcare workers make informed decisions when prescribing. This journal is recognized by the medical community as an authoritative resource, known for its high-quality content and deep insights into clinical practice. The emphasis on the independence of information, which means that the content provided is not influenced by pharmaceutical companies, ensures the objectivity and impartiality of the information. This is critical for medical professionals as it helps them make treatment choices based on the best evidence, rather than commercial interests.
The content of the journal usually includes the latest research results of drugs, guidelines for drug use, treatment guidelines, drug safety information, and drug interactions. Through this content, healthcare professionals are able to obtain the latest knowledge about drug use, including the launch of new drugs, new uses of existing drugs, and the applicability of drugs in specific patient populations.
按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科:PHARMACOLOGY & PHARMACY
收錄子集:ESCI
分區(qū):Q2
排名:105 / 354
百分位:
70.5% |
按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科:PHARMACOLOGY & PHARMACY
收錄子集:ESCI
分區(qū):Q2
排名:125 / 354
百分位:
64.83% |
JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨(dú)特的多學(xué)科期刊評價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個具體學(xué)科。JCR分區(qū)根據(jù)每個學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。
學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
大類:Medicine 小類:Pharmacology (medical) | Q2 | 132 / 272 |
51% |
該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時(shí)間都較長,投稿過審時(shí)間平均 12周,或約稿 ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。
若用戶需要出版服務(wù),請聯(lián)系出版商:NATIONAL PRESCRIBING SERVICE LTD, SUITE 3, 2 PHIPPS CLOSE, DEAKIN, AUSTRALIA, ACT 2600。